NBCD A/S: Financial statements 2019
CVR: 30582462
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
NBCD A/S (CVR 30582462) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 48,913,734 and a net result of DKK 33,733,642 compared with DKK 16,252,006 the year before. That is an increase of 82.9% compared with the year before. Equity in the 2019 report amounted to DKK 36,486,238. The solvency ratio was 41.4%. The company had 20 employees in the financial year.
- Gross Profit
- DKK 48,913,734
- Profit/Loss
- DKK 33,733,642
- Equity
- DKK 36,486,238
- Total Assets
- DKK 88,130,177
- Employees
- 20
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 48.9 mio. | 33.7 mio. | 36.5 mio. | 20 |
| 2018 | - | 26.7 mio. | 16.3 mio. | 17.8 mio. | 25 |
| 2017 | - | 24.6 mio. | 20.8 mio. | 21.5 mio. | - |
| 2016 | - | 12.7 mio. | 14 mio. | 9.7 mio. | - |
| 2015 | - | -6.1 mio. | 37.9 mio. | 44.2 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
NBCD A/S has published its annual report for 2018. Gross profit came to DKK 26,749,241, and the net result was DKK 16,252,006.
About NBCD A/S
NBCD A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2007. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S and NORDIC BIOSCIENCE PROJECT 2 A/S. The management consists of Jeppe Ragnar Andersen and Mark Høgh Gandrup. The board consists of Pierre Khaitrine (chair), Jeppe Ragnar Andersen and José Ignacio Pfeifer. The company is owned by Sanos Holding A/S. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 31,583,144 and a net result of DKK 9,222,892 compared with DKK 52,621,101 the year before. Equity in the 2025 report amounted to DKK 136,144,994.